Secondary endpoints include time to first acute protocol-defined pulmonary exacerbation , number of acute pulmonary exacerbations , number of hospitalization days for acute pulmonary exacerbation , time from the end of acute pulmonary exacerbation to onset of subsequent pulmonary exacerbation , change in health related quality of life , change in treatment burden , change in CF respiratory symptoms , and adherence to the study protocol .
